 |
[Alpha Biz=(Chicago) Reporter Kim Jisun] Celltrion Group announced on the 14th that the total amount of stock purchase claims for the merger between Celltrion and Celltrion Healthcare totaled 7.9 billion won.
The number of shares tallied by the exercise of stock purchase claims is 41,972 shares of Celltrion (about 6.3 billion won) and 23,786 shares of Celltrion Healthcare (about 1.6 billion won), respectively. Based on the total number of shares of both companies, the stock purchase claim was far below expectations, accounting for only 0.19% of the total number of shares opposed to the merger. The limit initially proposed by the company was worth KRW 1 trillion.
Seo Jung-jin, honorary chairman of Celltrion Group, earlier vowed to secure direct investment funds and digest all stock purchase claims even if the exercise of stock purchase claims exceeds KRW 1 trillion. The two companies, Celltrion and Celltrion Healthcare, announced plans to purchase additional shares worth 300 billion won after purchasing treasury stocks worth 55295 billion won by the 7th of this month.
The merged Celltrion is expected to focus on full-fledged growth after its launch on Dec. 28 while reducing its financial burden. If the listing of new shares is carried out on Jan. 12 next year, the merger between the two companies will be completed.
AlphaBIZ 김지선(stockmk2020@alphabiz.co.kr)
